48 results
8-K
EX-99.2
LRMR
Larimar Therapeutics Inc
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
University School of Medicine. In addition, she completed dual specialty training in the Pediatrics and Clinical Genetics residency program at Case … of Medicine where he directs multiple NIH-funded training, clinical, and research programs as a principal investigator. Dr. Payne received his BS
8-K
EX-99.1
LRMR
Larimar Therapeutics Inc
8 Dec 20
Regulation FD Disclosure
7:40am
from the George Washington University School of Medicine. In addition, she completed dual specialty training in the Pediatrics and Clinical Genetics … at Indiana University School of Medicine where he directs multiple NIH-funded training, clinical, and research programs as a principal investigator. Dr
8-K
LRMR
Larimar Therapeutics Inc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
and research training in internal medicine and nephrology at Thomas Jefferson University. Dr. Ben-Maimon’s qualifications to sit on the Board include her
10-K/A
2015 FY
LRMR
Larimar Therapeutics Inc
29 Apr 16
Annual report (amended)
12:00am
as an HR and Training Manager and in multiple commercial roles. Mr. Loustau holds a Maitrise in Physiology from the University Paris-XI in Orsay, a DEA
8-K/A
EX-99.2
ubixgriv qvod
26 Jun 20
Other Events
5:08pm
10-Q
cqyme410 yvobqaexlx
14 Aug 14
Quarterly report
12:00am
PRE 14A
agxmaw n6yaz9g573idq
12 Apr 24
Preliminary proxy
6:06am
424B4
ej5mrl7epxi96kkj5f0
19 Jun 14
Prospectus supplement with pricing info
12:00am